DOES THE METABOLITE URACIL ARABINOSIDE INHIBIT CYTOSINE-ARABINOSIDE (ARA-C) PENETRATION INTO THE CEREBROSPINAL-FLUID DURING HIGH-DOSE ARA-C THERAPY

被引:0
|
作者
VANPROOIJEN, HC
MUUS, P
ROELOFS, JMM
PUNT, K
机构
[1] STATE UNIV UTRECHT,DEPT BIOCHEM,UTRECHT,NETHERLANDS
[2] ST RADBOUD HOSP,DEPT HAEMATOL,NIJMEGEN,NETHERLANDS
来源
SCANDINAVIAN JOURNAL OF HAEMATOLOGY | 1986年 / 36卷 / 01期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [41] SYNERGISTIC INTERACTIONS OF CYTOSINE-ARABINOSIDE (ARA-C), THYMIDINE (TDR), AND HYDROXY UREA (HU)
    STREIFEL, JA
    HOWELL, SB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 176 - 176
  • [42] THE METABOLISM AND CYTO-TOXIC EFFECTS OF CYTOSINE-ARABINOSIDE (ARA-C) AND GUANINE ARABINOSIDE (ARA-G) IN HUMAN-LYMPHOBLASTS
    MITCHELL, BS
    SHEWACH, DS
    ASHCRAFT, E
    CLINICAL RESEARCH, 1983, 31 (04): : A778 - A778
  • [43] COMBINED ACLACINOMYCIN (ACM) AND CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY TREATED AML PATIENTS
    MACHOVER, D
    VANDENBULCKE, JM
    BAUME, D
    MISSET, JL
    MATHE, G
    ANTICANCER RESEARCH, 1985, 5 (06) : 635 - 635
  • [44] DOCUMENTATION OF A CASE OF CYTOSINE-ARABINOSIDE (ARA-C) TOXICITY USING DRUG-MONITORING
    WERMELING, JR
    PRUEMER, JM
    SIGMUND, D
    PESCE, AJ
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1182 - 1182
  • [45] BIOCHEMICAL AND CYTOCHEMICAL EFFECTS OF CYTOSINE-ARABINOSIDE (ARA-C) AND HYDROCORTISONE ON HELA-CELLS
    DANCONA, S
    ADAMI, P
    POLTRONIERI, R
    BARBERIO, MT
    RIZZOTTI, P
    TUMORI, 1979, 65 (01) : 19 - 26
  • [46] TREATMENT OF REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA WITH PYRAZOFURIN (PZF) AND CYTOSINE-ARABINOSIDE (ARA-C)
    KAPLAN, H
    APPELBAUM, F
    CHEEVER, M
    WOOD, T
    GREENBERG, P
    EINSTEIN, A
    FEFER, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 168 - 168
  • [47] DEVELOPMENT OF BEHAVIORAL FUNCTION OF CEREBELLAR HYPOPLASIA RATS AS INDUCED BY CYTOSINE-ARABINOSIDE (ARA-C)
    OGURA, H
    MIKAMI, T
    TAKAMURA, N
    SUZUKI, Y
    CHIBA, T
    FOLIA PHARMACOLOGICA JAPONICA, 1980, 76 (01) : 33 - 44
  • [48] TREATMENT OF MINIMAL RESIDUAL DISEASE IN POOR RISK ACUTE LYMPHOBLASTIC-LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    BARNETT, MJ
    KINGSTON, JE
    MILLER, A
    GOFF, LK
    GANESAN, TS
    BIRULS, R
    ROHATINER, AZS
    MALPAS, JS
    LISTER, TA
    LEUKEMIA RESEARCH, 1986, 10 (01) : 90 - 90
  • [49] A FEASIBILITY STUDY OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) AS PRIMARY-TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    CURTIS, JE
    MESSNER, HA
    MINDEN, MD
    MCCULLOCH, EA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [50] TOXICITY OF INTRATHECAL CYTOSINE ARABINOSIDE (ARA-C) AND PHENYLALANINE MUSTARD IN MONKEYS
    WALKER, MD
    DALGARD, DW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1968, 9 (MAR): : 75 - &